ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Debt / NOTE 4.000%11/1
Number of holders
16
Total Principal
206M
Shares change
-2.67M
Total reported value, excl. options
$256M
Value change
-$4.68M
Put/Call ratio
0
Number of buys
6
Number of sells
-12
Price
$0.95
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.